Assort Health Raises $76 Million to Scale Agentic AI Healthcare Platform

Assort Health has raised $76 million in a Series B funding round led by Lightspeed Venture Partners. The round included participation from Felicis, First Round Capital, Chemistry, A*, Liquid2 Ventures, and Quiet Capital. Lightspeed partner Galym Imanbayev will also join the board while Paul Ricci, founding CEO of Nuance, will join as a board advisor.

This fresh capital brings Assort Health’s total funding to $102 million. Founded by Jeffery Liu and Jon Wang, their goal is to accelerate the growth of their comprehensive patient experience platform, Assort OS. The platform has already handled tens of millions of patient interactions across thousands of providers, aiming to transform patient experience.

Booking a doctor’s appointment is still a huge headache for millions of people. Patients face endless hold times, dropped calls, constantly being transferred around, and having to repeat their information over and over. These frustrations often lead to missed appointments and gaps in care. In fact, according to the American Academy of Physician Associates, adults in the U.S. spend about as much time each month just trying to navigate healthcare as they do working a full day.

Jeffery and Jon lived through this frustration firsthand. After spending two years digging into how healthcare operates, they started Assort Health in 2023 with a clear goal. To use agentic AI to improve patient engagement and reduce access barriers.